Vimarsana
Biggest News Aggregation in the World

Page 4 - 03525510 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 03525510. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 03525510 Today - Breaking & Trending Today

14,627 Shares in Anika Therapeutics, Inc. (NASDAQ:ANIK) Acquired by Great West Life Assurance Co. Can - Vimarsana News

14,627 Shares in Anika Therapeutics, Inc. (NASDAQ:ANIK) Acquired by Great West Life Assurance Co. Can

Great West Life Assurance Co. Can bought a new position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,627 shares of the biotechnology company’s stock, valued at approximately $348,000. Other large […]

Financial Survey: Anika Therapeutics (NASDAQ:ANIK) versus Nemaura Medical (NASDAQ:NMRD) - Vimarsana News

Financial Survey: Anika Therapeutics (NASDAQ:ANIK) versus Nemaura Medical (NASDAQ:NMRD)

Anika Therapeutics (NASDAQ:ANIK – Get Rating) and Nemaura Medical (NASDAQ:NMRD – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Anika Therapeutics and Nemaura Medical’s […]

Anika Therapeutics (NASDAQ:ANIK) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS - Vimarsana News

Anika Therapeutics (NASDAQ:ANIK) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Anika Therapeutics (NASDAQ:ANIK – Get Rating) posted its earnings results on Thursday. The biotechnology company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.04, MarketWatch Earnings reports. Anika Therapeutics had a negative return on equity of 0.11% and a net margin of 2.80%. During the same period in the prior […]

Riverwater Partners LLC Acquires New Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Vimarsana News

Riverwater Partners LLC Acquires New Position in Anika Therapeutics, Inc. (NASDAQ:ANIK)

Riverwater Partners LLC purchased a new position in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,096 shares of the biotechnology company’s stock, valued at approximately $326,000. Riverwater Partners LLC […]

Anika Therapeutics, Inc. (NASDAQ:ANIK) Given Average Recommendation of "Hold" by Analysts - Vimarsana News

Anika Therapeutics, Inc. (NASDAQ:ANIK) Given Average Recommendation of "Hold" by Analysts

Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) have been assigned an average rating of “Hold” from the six brokerages that are covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating. The average twelve-month price objective among brokerages that have covered the stock in the last year […]